Hypersensitivity myocarditis and hepatitis associated with imipramine and its metabolite, desipramine.
We present two cases of myocarditis and hepatitis with histologic characteristics of hypersensitivity-mediated drug reactions associated with imipramine and its metabolite, desipramine. In one case, death was directly attributed to myocarditis; in the second case, the patient died of an acute myocardial infarct, but myocarditis may have played a contributory role. One patient was taking imipramine, and therapeutic concentrations of imipramine and desipramine were documented in postmortem blood. The other patient was receiving desipramine documented by in-patient hospital medication records. Both cases had liver lesions associated in the medical literature with adverse drug reaction to imipramine. Although myocarditis has been previously associated with amitriptyline, these cases appear to be the first reported in association with imipramine/desipramine. The fact that one patient was taking only desipramine suggests that it may be the offending agent.
Office of the Chief Medical Examiner, Burlington, VT.
P L
PL
Morrow
N J
NJ
Hardin
J
J
Bonadies
D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003891:Desipramine / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications*; D005260:Female; D006801:Humans; D007099:Imipramine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000139:chemically induced*
D007099:Imipramine; D003891:Desipramine